To view this email as a web page, click here

Today's Rundown

Featured Story

Gilead pens $1.5B buyout option deal for Pionyr

As it continues with its small to medium-sized biotech deals, Gilead has put down $275 million for a 49.9% share in immuno-oncology biotech Pionyr with the option to buy it out completely should it pass muster in early clinical tests.

read more

Top Stories

Sanofi's en route to more internal innovation, but M&A will tide it over: exec

Paul Hudson wasted no time when he took the reins at Sanofi, unveiling plans to ditch the company's weakest R&D units and double down on cancer, rare diseases and other “growth drivers” within his first 100 days. Six months on, head of development Dietmar Berger reflects on the R&D shakeup.

read more

Bayer-backed Century buys Empirica to create brain cancer CAR-Ts

Century Therapeutics has bought Empirica to drive development of allogeneic cell therapies against the brain cancer glioblastoma. The induced pluripotent stem cell (IPSC) player, which landed a $215 million investment from Bayer last year, acquired Empirica on the strength of work to create a CAR-T treatment for glioblastoma.

read more

Sponsored: Rise in Targeted Therapies Drives Need for Flexible Small-Volume Manufacturing

Innovative therapies target small numbers of patients. Smaller demand for a therapy, means that sterile injectable manufacturing needs to accommodate smaller batch sizes and more flexibility.

read more

Sarepta taps Codiak's exosome tech in $72.5M neuromuscular disease deal

Sarepta is on the hunt for new ways to deliver genetic medicines. Its latest target? A system the body’s cells use to communicate with each other. The company is teaming up with Codiak Biosciences to develop engineered exosomes that can deliver gene therapy, gene editing or RNA-based treatments.

read more

Sanofi spends $425M to double down on Translate Bio mRNA pact, eyes Q4 COVID-19 vax start

Sanofi Pasteur is betting big on its pact with mRNA biotech Translate Bio as it deepens its ties and commitment to infectious disease vaccines using this new tech.

read more

Giving highly funded but secretive Moderna a run for its money, Juno-lite Sana raises $700M

Sana Biotechnology has got some major backing after coming out with a huge $700 million initial funding round and the ex-financial and research team from Juno Therapeutics.

read more

Schrödinger, Google Cloud to supply massively parallel computing efforts to global COVID-19 initiative

Digital molecule designer Schrödinger is expanding its efforts against the novel coronavirus, using its partnership with Google’s cloud computing division to screen new potential antivirals as part of a global Big Pharma collaboration.

read more

Enrollment Showcase

A Credential for the Future of Health Care

Position yourself as a precision medicine leader with the online graduate program in precision medicine. Learn the latest in genomic technologies and precision medicine therapies from experts in research and implementation. Join the future of health care with the flexibility and convenience of an online program.

Resources

On-Demand Video: Fuel gene therapy development and production with modern AAV workflows

On-demand video: fuel gene therapy development and production with modern AAV workflows.

eBook: SUPERCHARGE INNOVATION: UNLEASH THE FULL FORCE OF LIFE SCIENCES

Built on advances in Artificial Intelligence (AI), data mining, and information integration into various systems at 100% accuracy, the new era of intelligent automation is integral to life sciences for devising new treatments faster and at a lower expense.

Case Study: Pharma Sponsor Enlists Cenduit to Rescue a Multi-Country, Multi-Site Oncology Study

Download this case study to read how Cenduit helped one client successfully navigate mid-study changes to medication management.

Whitepaper: 4 Ways to Keep Pace with Big Pharma, Even On a Start-Up Budget

Learn four ways to squeeze more value from your limited R&D resources.

eBook: Advanced Analytical Approaches for Improved Development of Cell and Gene Therapies

Download this eBook and Learn the Advanced Analytical Approaches for Improved Development of Cell and Gene Therapies

Whitepaper: Brand Revitalization with RP Scherer Softgel Solutions for Analgesics

In a series of innovation sessions, Catalent RP Scherer softgel capsules were quickly identified as the ideal solution to drive incremental growth. Learn more.

Whitepaper: 7 Keys to Success in Europe

White paper describing 7 keys to success for any biopharma company that is entering (or thinking about entering) Europe.

Whitepaper: Rapid BYOD Build Timelines

This white paper covers a Phase III case study; BYOD advantages and misconceptions; and regulatory, copyright, and equivalency considerations.

Whitepaper: Keep Your GI Trials Moving During COVID-19

Learn how GI specific data capture solutions can support virtual and hybrid trials during COVID-19.

Whitepaper: The Evolution and Importance of Biomedical Ontologies for Scientific Literature

Dive into the history of biomedical classification and how these systems have evolved to address new technology and use cases.

Whitepaper: Pandemic respiratory vaccine clinical trials: a departure from business as usual

Download this whitepaper to learn more about the success factors that are required to keep a pandemic respiratory vaccine trial running at optimal speed and efficiency.

Case Study: Establishing Parameters for Success

Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study.

Fact Sheet: Forecasting to Optimize Clinical Trial Supply Management

Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study.

eBook: Expecting the Unexpected: Strategies for Efficient Clinical Supply Management and Forecasting

Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study.

Virtual Event: Cardiac Safety London Online

Join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss state of the art methods in early phase clinical research.

Events